318 Results

People

  1. Lesokhin
    Lesokhin
  2. Hassoun
    Hassoun
  3. Landau
    Landau
  4. Giralt
    Giralt
  5. Korde
    Korde
  6. Mailankody
    Mailankody
  7. Chung
    Chung
  8. Shah
    Shah
  9. Shah
    Shah
  10. Hultcrantz
    Hultcrantz

Groups

  1. Center for Hematologic Malignancies (318)
  2. Department of Medicine (318)
  3. Hematologic Malignancies Research (318)
  4. Hematologic Malignancies, Division of (318)
  5. Myeloma (318)
  6. Survivorship Research (181)
  7. Bone Marrow Transplant (164)
  8. Epidemiology and Biostatistics (137)
  9. Biostatistics Service (128)
  10. Sloan Kettering Institute Postdocs (122)
  1. "Hematologic Malignancies Research"
  2. "Alexander Lesokhin"
Formats
  1. Meeting Abstract (212)
  2. Journal Article (85)
  3. Research Letter (8)
  4. Review (7)
  5. Correspondence (3)
  6. Book Section (2)
  7. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (318)
  2. Department of Medicine (318)
  3. Hematologic Malignancies Research (318)
  4. Hematologic Malignancies, Division of (318)
  5. Myeloma (318)
  6. Survivorship Research (181)

More Groups

People
  1. Alexander Lesokhin (318)
  2. Hani Hassoun (164)
  3. Heather Landau (146)
  4. Sergio Giralt (144)
  5. David Chung (138)
  6. Neha Korde (132)

More People

Years
  1. 2024 (4)
  2. 2023 (74)
  3. 2022 (51)
  4. 2021 (31)
  5. 2020 (18)
  6. 2019 (21)

More Years

Publications
  1. Blood (116)
  2. Clinical Lymphoma, Myeloma and Leukemia (44)
  3. Journal of Clinical Oncology (34)
  4. Biology of Blood and Marrow Transplantation (13)
  5. Leukemia and Lymphoma (12)
  6. Blood Advances (7)

More Publications

Publishers
  1. American Society of Hematology (123)
  2. Elsevier Inc. (65)
  3. American Society of Clinical Oncology (34)
  4. Nature Publishing Group (20)
  5. American Association for Cancer Research (14)
  6. Taylor & Francis Group (12)

More Publishers

Results (318)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study
    Research Letter

    Castro, F.; Parikh, R.; Eustaquio, J. C.; Derkach, A.; Joseph, J. M.; Lesokhin, A. M.; Usmani, S. Z.; Shah, U. A.
    Leukemia (2024)

    Fulltext@MSK | Save
  • Soluble B-cell maturation antigen in multiple myeloma
    Review

    Costa, B. A.; Ortiz, R. J.; Lesokhin, A. M.; Richter, J.
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population
    Journal Article

    Joseph, J. M.; Hillengass, J.; Tang, L.; Lesokhin, A. M.; Landgren, O.; Usmani, S. Z.; Moysich, K. B.; McCann, S. E.; Shah, U. A.
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
    Journal Article

    Shah, U. A.; Moshier, E.; Derkach, A.; Huang, Y.; Mailankody, S.; Tan, C. R.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Dose escalation of ISB 1342, a novel CD38xCD3 bispecific antibody, in patients with relapsed / refractory multiple myeloma (RRMM)
    Meeting Abstract

    Kapoor, P.; Stevens, D. A.; Leleu, X.; Merzoug, K. B.; Karlin, L.; Manier, S.; Chalopin, T.; Hulin, C.; Perrot, A.; Berdeja, J. G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Long-term efficacy and safety of elranatamab monotherapy in the phase 2 magnetismm-3 trial in relapsed or refractory multiple myeloma (RRMM)
    Meeting Abstract

    Tomasson, M.; Iida, S.; Niesvizky, R.; Mohty, M.; Bahlis, N. J.; Martinez-Lopez, J.; Koehne, G.; Otero, P. R.; Prince, H. M.; Viqueira, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of elranatamab in Black patients with relapsed/refractory multiple myeloma (RRMM): A Subgroup analysis of the magnetismm studies
    Meeting Abstract

    Varshavsky-Yanovsky, A.; Jethava, Y.; Stevens, D. A.; Nooka, A. K.; Stiff, P. J.; Perez-Cruz, I.; Leip, E.; Lesokhin, A.
    Blood (2023)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals distinct mutational signatures in multiple myeloma patients with African ancestry compared with those of non-African ancestry
    Meeting Abstract

    Maclachlan, K. H.; Blaney, P.; Cirrincione, A.; Chu, T. R.; Poos, A. M.; Brown, E. E.; Manasanch, E. E.; Hoering, A.; Hou, L. M.; Gagler, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • T-cell exhaustion signature predicts early relapse after autologous stem cell transplant for multiple myeloma: BMT CTN 0702 secondary immune analysis
    Meeting Abstract

    Mehanna, N.; Derkach, A.; Gasmi, B.; Anagnostou, T.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Maclachlan, K. H.; more...
    Blood (2023)

    Fulltext@MSK | Save